Gemvax & Kael Co. Ltd.
- Address
- Techno 11 Ro 58
Sponsor Overview
Specializations
Alzheimer’s disease
Gemvax & Kael Co. Ltd. focuses its clinical research on Alzheimer’s disease, with an emphasis on mild to moderate cognitive impairment and cognition in affected participants.
- Neurodegenerative disease research
- Cognitive function assessment
- Safety evaluation in Alzheimer’s disease
The sponsor’s active trial portfolio includes work across multiple collaborating sites in Asia and other participating countries, reflecting a clinical interest centered on treatment options for Alzheimer’s disease.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of the Safety and Efficacy of Subcutaneous Tertomotide (GV1001) in Mild to Moderate Alzheimer's Disease: A Randomized, Double-Blind, Placebo-Controlled Study |  Finland France Italy Poland Portugal Spain The Netherlands | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 24 sites across their trial portfolio.
Therapeutic Focus
- 1.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
24 centres- Address
- Cronenburg 2, 1081 GN Amsterdam
- Address
- Statenlaan 37, 5223 LA S-Hertogenbosch
- Address
- Dokter Stolteweg 90, 8025 AZ Zwolle
- Address
- Via Giuseppe Dezza 48, 20144 Milan
- Address
- Lugar De Sete Fontes S Victor, 4710-243 Braga
- Address
- 165 Chemin Du Grand Revoyet, 69310 Pierre Benite
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Gemvax & Kael Co. Ltd..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.